These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
786 related articles for article (PubMed ID: 17137666)
1. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics. Geier MS; Butler RN; Howarth GS Int J Food Microbiol; 2007 Apr; 115(1):1-11. PubMed ID: 17137666 [TBL] [Abstract][Full Text] [Related]
2. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Hedin C; Whelan K; Lindsay JO Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082 [TBL] [Abstract][Full Text] [Related]
3. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease? Seksik P; Dray X; Sokol H; Marteau P Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087 [TBL] [Abstract][Full Text] [Related]
5. Gut microbiota and inflammatory bowel disease. Hammer HF Dig Dis; 2011; 29(6):550-3. PubMed ID: 22179210 [TBL] [Abstract][Full Text] [Related]
6. Clinical usefulness of probiotics in inflammatory bowel diseases. Mach T J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():23-33. PubMed ID: 17242485 [TBL] [Abstract][Full Text] [Related]
7. Food-based strategies to modulate the composition of the intestinal microbiota and their associated health effects. Bosscher D; Breynaert A; Pieters L; Hermans N J Physiol Pharmacol; 2009 Dec; 60 Suppl 6():5-11. PubMed ID: 20224145 [TBL] [Abstract][Full Text] [Related]
8. Probiotics, prebiotics, and synbiotics. de Vrese M; Schrezenmeir J Adv Biochem Eng Biotechnol; 2008; 111():1-66. PubMed ID: 18461293 [TBL] [Abstract][Full Text] [Related]
10. Review article: probiotics and prebiotics in irritable bowel syndrome. Spiller R Aliment Pharmacol Ther; 2008 Aug; 28(4):385-96. PubMed ID: 18532993 [TBL] [Abstract][Full Text] [Related]
11. Understanding why probiotic therapies can be effective in treating IBD. Fedorak RN J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S111-5. PubMed ID: 18806699 [TBL] [Abstract][Full Text] [Related]
12. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease. Mitsuyama K; Sata M Expert Opin Ther Targets; 2008 Mar; 12(3):301-12. PubMed ID: 18269340 [TBL] [Abstract][Full Text] [Related]
13. Microecology as a target for therapeutic intervention in inflammatory bowel disease. Guarner F IDrugs; 2003 Sep; 6(9):868-73. PubMed ID: 12964066 [TBL] [Abstract][Full Text] [Related]
14. Clinical utility of probiotics in inflammatory bowel disease. Cain AM; Karpa KD Altern Ther Health Med; 2011; 17(1):72-9. PubMed ID: 21614946 [TBL] [Abstract][Full Text] [Related]
15. Probiotics. Gupta V; Garg R Indian J Med Microbiol; 2009; 27(3):202-9. PubMed ID: 19584499 [TBL] [Abstract][Full Text] [Related]